Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Hye‐Sol Jung is a leading hepatobiliary and pancreatic surgeon whose work is redefining the frontiers of minimally invasive oncology. Her research centers on the safety, feasibility, and long-term efficacy of robotic surgery for complex malignancies of the gallbladder and pancreas. Dr. Jung’s major contributions include demonstrating the oncologic safety of robotic extended cholecystectomy for gallbladder cancer and advancing the technique of robot-assisted pancreaticoduodenectomy (RPD) for pancreatic cancer. Her landmark study on current trends, analyzing 630 consecutive RPD cases, highlights the dramatic shift toward robotic approaches in high-volume centers. Crucially, her comparative research on long-term oncologic outcomes between RPD and open surgery provides vital evidence supporting the robotic platform’s role in achieving curative resection. She has also pioneered the evaluation of RPD following neoadjuvant treatment for advanced pancreatic ductal adenocarcinoma, proving its feasibility in this challenging patient cohort. With her most cited work accumulating over 20 citations in just a few years, Dr. Jung is establishing the evidence base that is rapidly transforming pancreatic and biliary surgery, offering patients the promise of reduced recovery times without compromising cancer survival.